Company intelligence / Profile preview

GiantMed

Ownership: Private
Development stage: Other

Overview

GiantMed, officially known as Beijing Giantmed Medical Laboratory Co., Ltd, is an active Chinese company founded in 2016 specializing in research and experimental development within the healthcare sector. The group also operates under the name "Giant Med-Pharm Service Group," with leadership including President Mike Lu. The company's primary activities appear to center around medical laboratory services and possibly contract research or diagnostics for life sciences clients. No evidence was found of proprietary drug development programs or clinical-stage therapeutics.

Modalities: Diagnostic assays
Industry: Contract Research Organization

Beyond the preview

Go deeper on GiantMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GiantMed.

Explore the full profile